Optimind Pharma Corp. (CSE:OMND)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
Aug 19, 2025, 1:59 PM EST

Optimind Pharma Financials Overview

Millions CAD. Fiscal year is Mar - Feb.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Revenue
0.120.120.120.120.170.1
Revenue Growth
2.47%2.47%-3.73%-27.72%70.64%-
Gross Profit
0.080.080.070.060.050.06
Operating Income
-0.04-0.04-0.2-0.75-0.91-0.4
Net Income
-0.12-0.12-0.22-1.4-3.08-0.28
Earnings Per Share
-0.00-0.00-0.00-0.01-0.04-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Investments
0.10.10.080.030.551.35
Total Debt
0.120.120.130.130.610.13
Net Cash (Debt)
-0.02-0.02-0.04-0.1-0.061.22
Net Cash Growth
------
Net Cash Per Share
-0.00-0.00-0.00-0.00-0.000.03

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Operating Cash Flow
0.020.02-0.21-0.47-1.04-0.23
Free Cash Flow
0.020.02-0.21-0.47-1.04-0.23
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingFeb '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Gross Margin
62.33%62.33%58.27%47.63%30.49%63.89%
Operating Margin
-35.27%-35.27%-170.38%-612.59%-533.41%-405.39%
Pretax Margin
-97.23%-97.23%-182.32%-1143.75%-1814.78%-422.53%
Profit Margin
-97.23%-97.23%-182.32%-1136.63%-1809.57%-278.57%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
PS Ratio
4.254.254.643.9923.01-